# Arch: portfolio, investments and team

> Arch is a hedge fund. 26 investments on record, 1 in the last 12 months, latest May 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/arch (Millionrounds; every figure on the page links to its filing or article)

[Investor](https://millionrounds.com/investors)

# Arch

Last cheque observed May 2026; 26 cheques on record.

Email

Deploying now Hedge fund Website unconfirmed

Series A Series B Series C Software Wealth Management

Follow Arch and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Farch)

Deploying now

**100%** of best year **1** **cheques in 12 months**, 26 on record

Since the last cheque **169** days **00** hrs **00** min **00** sec

Median round **$44M** Rounds led **0 of 26** Mostly in **United States, 88%**

Pitch Arch

## Arch highlights

- 01 1 cheques in the last 12 months
- 02 Mostly Series A and Series B: 68% of its rounds

## What they do

- **Type:** Hedge fund (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Software Wealth Management
- **Cold pitches:** Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=arch).

## The record

Every round we can evidence, newest first **26 appearances**

- **2026** 1 round
- **May** **[Novella](https://millionrounds.com/company/novella)** Series A · US · Ventureburn **$21M** With 7 others
- **2019** 4 rounds
- **May** **[Verve Therapeutics](https://millionrounds.com/company/verve-therapeutics)** Series A · US · FinSMEs **$59M** With 3 others
- **Apr** **[908 Devices](https://millionrounds.com/company/908-devices)** Series E · US · FinSMEs **$18M** With 7 others
- **Mar** **[Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics)** Series B · US · FinSMEs **$135M** With 7 others
- **Mar** **[Erasca](https://millionrounds.com/company/erasca)** Series A · US · FinSMEs **$64M** With 2 others
- **2018** 10 rounds
- **Aug** **[Magnolia Neuroscience](https://millionrounds.com/company/magnolia-neuroscience)** Series A · US · FinSMEs **$31M** With 10 others
- **Jul** **[Omniome](https://millionrounds.com/company/omniome)** Series B · US · FinSMEs **$60M** With 6 others
- **Jul** **[Gossamer Bio](https://millionrounds.com/company/gossamer-bio)** Series B · US · Biospace **$230M** With 4 others
- **Jul** **[AgBiome](https://millionrounds.com/company/agbiome)** Series C · US · FinSMEs **$65M** With 5 others
- **Jun** **[Just Biotherapeutics](https://millionrounds.com/company/just-biotherapeutics)** Series B · CN · FinSMEs **$35M** With 4 others
- **Jun** **[Cytrellis](https://millionrounds.com/company/cytrellis)** Series B · US · FinSMEs **$29M** With 3 others
- **May** **[Brii Bio](https://millionrounds.com/company/brii-bio)** CN · FinSMEs **$260M** With 5 others
- **May** **[CStone](https://millionrounds.com/company/cstone)** Series B · CN · FinSMEs **$260M** With 13 others
- **May** **[Luna DNA](https://millionrounds.com/company/luna-dna)** US · FinSMEs **$4.0M** With 4 others
- **Mar** **[Unity](https://millionrounds.com/company/unity)** Series C · US · FinSMEs **$55M** With 11 others
- **2017** 11 rounds
- **Nov** **[Codiak](https://millionrounds.com/company/codiak)** Series C · US · FinSMEs **$77M** With 8 others
- **Nov** **[ImmusanT](https://millionrounds.com/company/immusant)** Series C · US · FinSMEs **$40M** With 1 other
- **Oct** **[KSQ Therapeutics](https://millionrounds.com/company/ksq-therapeutics)** US · FinSMEs **$76M** With 2 others
- **Sept** **[LifeMine Therapeutics](https://millionrounds.com/company/lifemine-therapeutics)** Series A · US · FinSMEs **$55M** With 6 others
- **Jul** **[Rodeo Therapeutics](https://millionrounds.com/company/rodeo-therapeutics)** Series A · US · FinSMEs **$5.9M** With 7 others
- **May** **[Aira](https://millionrounds.com/company/aira)** Series B · US · FinSMEs **$12M** With 4 others
- **Mar** **[908 Devices](https://millionrounds.com/company/908-devices)** Growth · US · FinSMEs **$20M** With 6 others
- **Mar** **[OncoResponse](https://millionrounds.com/company/oncoresponse)** Series A · US · FinSMEs **$23M** With 8 others
- **Mar** **[Aledade](https://millionrounds.com/company/aledade)** Series D · US · Baltimore **$20M** With 3 others
- **Mar** **[Boragen](https://millionrounds.com/company/boragen)** Series A · US · FinSMEs **$10M** With 9 others
- **Jan** **[Scholar Rock](https://millionrounds.com/company/scholar-rock)** Series C · US · FinSMEs **$47M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## The cheque

Series A Series B Series C

Median round joined **$44M** the round, not its cheque

Led 0 of 26 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** May 2026

Rounds by stage said on their site

- Series A *8*
- Series B *7*
- Series C *5*
- Growth *1*
- Series D *1*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 6
- [Fidelity](https://millionrounds.com/fund/fidelity) 4
- [6 Dimensions Capital](https://millionrounds.com/fund/6-dimensions-capital) 3
- [Biomatics Capital](https://millionrounds.com/fund/biomatics-capital) 3
- [Boyu Capital](https://millionrounds.com/fund/boyu-capital) 3
- [Casdin Capital](https://millionrounds.com/fund/casdin-capital) 3

**Pitching Arch?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Arch. A count of rooms they were both in, not a relationship either has claimed.

[**Alexandria Real Estate Equities** VC firm **6** rounds together](https://millionrounds.com/fund/alexandria)[**Fidelity** VC firm **4** rounds together](https://millionrounds.com/fund/fidelity)[**6 Dimensions Capital** VC firm **3** rounds together](https://millionrounds.com/fund/6-dimensions-capital)[**Biomatics Capital** VC firm **3** rounds together](https://millionrounds.com/fund/biomatics-capital)[**Boyu Capital** Private equity **3** rounds together](https://millionrounds.com/fund/boyu-capital)[**Casdin Capital** VC firm **3** rounds together](https://millionrounds.com/fund/casdin-capital)[**EcoR1 Capital** Private equity **3** rounds together](https://millionrounds.com/fund/ecor1-capital)[**Goldbell Group** Growth equity **3** rounds together](https://millionrounds.com/fund/polaris)[**Google Ventures** Corporate VC **3** rounds together](https://millionrounds.com/fund/gv)[**AbbVie** Corporate VC **2** rounds together](https://millionrounds.com/fund/abbvie)[**Altitude Life Science Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/altitude-life-science-ventures)[**Blue Pool Capital** Private equity **2** rounds together](https://millionrounds.com/fund/blue-pool-capital)

## Recently backed

The latest companies Arch put money into.

[**Verve Therapeutics** $59M · May 2019](https://millionrounds.com/company/verve-therapeutics)[**908 Devices** $18M · Apr 2019](https://millionrounds.com/company/908-devices)[**Beam Therapeutics** $135M · Mar 2019](https://millionrounds.com/company/beam-therapeutics)[**Erasca** $64M · Mar 2019](https://millionrounds.com/company/erasca)[**Gossamer Bio** $230M · Jul 2018](https://millionrounds.com/company/gossamer-bio)[**AgBiome** $65M · Jul 2018](https://millionrounds.com/company/agbiome)

## Quick answers about Arch

### What does Arch invest in?

Arch invests most often at Series A and Series B (68% of the rounds on record), in sectors such as Software and Wealth Management.

### How active is Arch?

26 investments on record, 1 of them in the last 12 months. The most recent was in May 2026.

### What has Arch invested in recently?

Its most recent investments on record: Novella (Series A, May 2026), Verve Therapeutics (Series A, May 2019) and 908 Devices (Series E, Apr 2019).

### How big are Arch's cheques?

The median round it joins is $44M.

### Does Arch lead rounds?

Rarely, if at all: none of its 26 investments on record names it as the lead.

### Where does Arch invest?

Most of the companies it backs are in the United States (88%) and China (12%).

### Is Arch investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

### Who does Arch invest alongside?

Most often Alexandria Real Estate Equities (6 rounds together), Fidelity (4 rounds together) and 6 Dimensions Capital (3 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=arch) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=arch)